ASHLYNN BENNETT: Open Payments
NPI 1619345402 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,951 in 129 payments from 21 companies in 2025. Trend: 2023 $1,527 · 2024 $2,042 · 2025 $1,951
Food & beverage: $1,851Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $268 |
| ABBVIE INC. | 29 | $233 |
| Janssen Biotech, Inc. | 10 | $229 |
| UCB, Inc. | 14 | $191 |
| GENZYME CORPORATION | 7 | $180 |
| Incyte Corporation | 8 | $141 |
| Galderma Laboratories, L.P. | 12 | $138 |
| Lilly USA, LLC | 4 | $105 |
| LEO Pharma Inc. | 3 | $101 |
| Organon LLC | 5 | $70 |
Products named: COSENTYX, TREMFYA, DUPIXENT, Bimzelx, OPZELURA, NEMLUVIO, RINVOQ, EBGLYSS.
Industry payments across MS — which companies pay providers there.
